Senior Director, US New Product Planning (ADPKD Lead)

USA (Hybrid)

$228K/yr – $342K/yrSenior LevelFull time

Posted 3 days ago

Job Summary

Own the US commercial launch readiness for early pipeline assets, translating global strategy into a concrete US launch plan, cross-functional capability building, and scalable organizational design to support successful market access and execution.

  • Lead US commercial strategy development with cross-functional partners
  • Shape launch milestones, readiness plans, and governance-ready recommendations
  • Ensure smooth transition from early planning to in-market execution

Job Description

Responsibilities

  • Represent the US commercial perspective on global asset teams for early pipeline assets, especially those approximately 4 years from launch
  • Lead development of US commercial strategy in partnership with global commercial, medical, market access, HEOR, analytics, operations, and finance
  • Translate asset strategy into a clear US launch blueprint, including: market development priorities, launch scenarios and key assumptions, capability requirements, organization design implications, field force and non-personal promotion considerations, budget and investment needs
  • Identify and frame key strategic choices related to: positioning, patient finding and market development, access and reimbursement readiness, evidence generation priorities, customer engagement model, patient services and support strategy
  • Develop milestone-based and scenario-based plans that prepare the organization for launch well before traditional pre-launch planning begins
  • Partner with cross-functional leaders to define the capabilities, talent, processes, and infrastructure needed for launch success
  • Help shape the Business Unit growth strategy by defining what is needed to successfully absorb and commercialize new assets within an expanding BU
  • Provide strategic input on US commercialization models, including implications for specialty, and institution-based markets
  • Support governance and executive decision-making with clear recommendations, tradeoffs, and risk assessments
  • Help ensure a smooth transition from early planning into launch readiness and in-market execution

Requirements

  • Significant experience in biotech or pharmaceutical commercial strategy, new product planning, marketing, launch strategy, or related roles
  • Meaningful experience in both:
  • US commercial/business roles
  • Global or enterprise asset/team roles
  • Demonstrated success in new product planning, pre-launch strategy, or launch planning
  • Deep experience in hematology and/or rare disease
  • Strong understanding of US commercialization in complex specialty markets, and related access, site-of-care, and reimbursement considerations
  • Proven ability to help build or scale commercial infrastructure for new assets entering an expanding Business Unit
  • Experience building or shaping resourcing plans, operating models, and capability roadmaps
  • Proven ability to influence senior stakeholders and lead through a matrixed environment

Benefits

  • From medical, dental and vision benefits to generous paid time off (including a week-long company shutdown in the Summer and the Winter), educational assistance programs including student loan repayment, a generous commuting subsidy, matching charitable donations, 401(k) and so much more.
Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

4.2 Glassdoor

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global headquarters is in Boston, and we have research and development (R&D) sites and commercial offices worldwide.Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/

Founded in 1989
Boston, Massachusetts, USA
6.1K employees (282 in marketing)
83% recommend to a friend
88% CEO approval

Salaries

Posted range

$228K/yr – $342K/yr

Taken straight from the job posting.

See all Vertex Pharmaceuticals salaries

Funding

Total Funding
$657.3M
Last Raise
$1.1M
Post IPO Secondary, 2 years ago

Funding History

  • Jul 2024
    Post IPO Secondary • $1.1M
  • May 2022
    Post IPO Equity • $50M
  • Dec 2009
    Post IPO Equity • $443M

Traffic Signals

Monthly Visitors
340.5K
Monthly Google Ads Budget
$44.9K
Traffic Source Mix
Search
36.6%
Direct
38.5%
Referral
22.7%
Social
1%
Paid
1.1%

Headcount Trend

Current headcount: ~6.2K

Recent News

Vertex Pharmaceuticals logo

Senior Director, US New Product Planning (ADPKD Lead)

Vertex Pharmaceuticals · USA · Hybrid